Pharmacy Times
NOVEMBER 6, 2022
Controlling blood pressure may be the most important type of treatment for vasculitis and lupus patients, said a professor of renal medicine at ASN Kidney Week in Orlando, Florida.
pharmaphorum
NOVEMBER 6, 2022
Eli Lilly plans for a new biopharmaceutical manufacturing facility in Ireland that will be used to produce active ingredients for its biologic medicines, including its new Alzheimer’s candidate donanemab, has been blocked by a planning objection. Lilly had already secured planning approval from Limerick City and County Council for the plant at the Raheen Business Park.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
NOVEMBER 6, 2022
Next-generation research shows that targeting specific Kir channels, which regulate salt reabsorption in the kidneys, could improve diuretic function in kidney patients.
Board Vitals - Pharmacist
NOVEMBER 6, 2022
While it seems we only just started 2022, time flies! The end of the year is fast approaching, and soon many clinicians will be in a hurry to complete their annual continuing medical education requirements. Those with employer-sponsored CME allowances will need to spend their remaining 2022 CME allowance by the December 31st deadline. Many CME activity providers offer ways to earn CME conveniently online and some even include a complimentary gift card to popular retailers such as Amazon.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
NOVEMBER 6, 2022
Active patient care with chronic kidney disease may provide enormous benefits for patients, the economy, and society.
Drug Store News
NOVEMBER 6, 2022
The Live, Love, Breathe Lung Exerciser is designed to help people with compromised respiratory systems increase the strength of the diaphragm and intercostal muscles around the lungs.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Store News
NOVEMBER 6, 2022
EBT SNAP payments are now accepted for Instacart orders placed from ShopRite, Fairway Market, Gourmet Garage and The Fresh Grocer stores.
Pharmacy Times
NOVEMBER 6, 2022
Daprodustat is suggested to improve anemia and quality-of-life in patients with chronic kidney disease.
The FDA Law Blog
NOVEMBER 6, 2022
By Sophia R. Gaulkin — We previously blogged about Pfizer’s copay assistance lawsuit, which sought to challenge HHS’s interpretation of the Federal health care program anti-kickback statute (AKS) and position that the company’s proposed copay assistance program would violate the AKS. Now, after an unfavorable HHS Office of the Inspector General (OIG) advisory opinion and two defeats in court, Pfizer has appealed the Second Circuit’s decision to the Supreme Court.
Pharmacy Times
NOVEMBER 6, 2022
American Society of Consultant Pharmacists executive director and CEO explained how staffing struggles in long-term care facilities can be an opportunity for pharmacists to expand the ways they provide support beyond immunizations alone.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Drug Store News
NOVEMBER 6, 2022
Together, VillageMD and Summit Health will have more than 680 provider locations in 26 markets.
Pharmacy Times
NOVEMBER 6, 2022
Experts said the results will likely not alter practice and clinicians will likely continue to use torsemide.
Drug Store News
NOVEMBER 6, 2022
Ninety-eight percent of community pharmacies are experiencing drug shortages, according to a recent survey conducted by NCPA.
Hospital Pharmacy Europe
NOVEMBER 6, 2022
A full spectrum cannabidiol solution significantly reduced anxiety levels and improved several measures of cognition in a recent small study. Cannabidiol (CBD) given as a full-spectrum (i.e., containing all the components in the plant) solution, has been found to significantly reduce anxiety levels but it also appeared to improve scores on several cognitive-related tests according to the findings in a small, open-label study by US researchers.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Store News
NOVEMBER 6, 2022
Cardinal Health's Q1 revenue was $49.6 billion, an increase of 13% from the prior year period.
PharmExec
NOVEMBER 6, 2022
Here are three mindsets for pharma companies to adopt now to reap the rewards of early action in the metaverse.
Drug Store News
NOVEMBER 6, 2022
Join Surescripts’ Andrew Mellin, MD, and Cecelia Byers, PharmD, as they share clinical insights on the prescriber and pharmacist experience and how tech can play a role in addressing time-consuming administrative tasks, while saving patients money an.
pharmaphorum
NOVEMBER 6, 2022
The potential of monoclonal antibodies (mAbs) as therapies is indisputable. The current mAbs market is expected to be around ~USD 150 billion. In 2021, five out of the top 10 selling drugs were mAbs and this trend is forecasted to remain the same over the next five years. Naturally, the pharma industry has seen an explosion of mAbs in the pipeline, which has led to the evolution of new methods for improving and refining the antibody pipeline.
Drug Store News
NOVEMBER 6, 2022
The investment from 5th Century Partners will be used by the brand to help fund its ambitions, domestic and global expansions and new product innovations.
pharmaphorum
NOVEMBER 6, 2022
AstraZeneca and Sanofi have secured approval in the EU for Beyfortus, the first single-dose drug to protect newborns and infants from respiratory syncytial virus (RSV) infections. The antibody-based drug has been cleared by the European Commission with a broad label, covering both full-term and pre-term babies and those with a range of health conditions that could make the vulnerable to RSV, said the two pharma groups in a statement.
Drug Store News
NOVEMBER 6, 2022
Ketorolac tromethamine is indicated for the short-term management of moderately severe acute pain in adult patients.
Expert insights. Personalized for you.
145 
Let's personalize your content